Study Aim: Immunohistochemical screening of hMLH1 and hMSH2 gene mutations in patients diagnosed with colorectal cancers, suspected of having microsatellite instability, as diagnosed between January 2002 and December 2009 in the Surgery Department of the CF Clinical Hospital Cluj-Napoca (prospective non-randomised study).
Methods: Inclusion criteria were adenocarcinoma pathology finding and also minimum one of the revised Bethesda criteria for genetic testing of microsatellite instability in colorectal cancers. 110 eligible patients were divided in 2 study groups according to the number of Bethesda criteria met (group A - 1 criteria; group B - 2 or more criteria). Both groups were statistically compared considering the clinical and pathological parameters specific to the Lynch syndrome. We performed immunohistochemical staining to determine the expression of hMLH1 and hMSH2 genes in the tumors of all the patients.
Results: We found the differences in age, colorectal family history and right colon tumor site between the two groups to be statistically significant. Immunohistochemical stainings showed lack of hMLH1 gene expresion in 9 patients and of hMSH2 gene in 4 patients respectively.
Conclusions: Immunohistochemical staining can identify patients who need to be genetically tested for mutations of the DNA mismatch repair genes, in order to establish the correct diagnostic of Lynch syndrome.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
BRAF immunohistochemistry can reliably substitute BRAF molecular testing in the Lynch syndrome screening algorithm in colorectal cancer.
Histopathology
April 2024
IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Aims: The Lynch syndrome (LS) screening algorithm requires BRAF testing as a fundamental step to distinguish sporadic from LS-associated colorectal carcinomas (CRC). BRAF testing by immunohistochemistry (IHC) has shown variable results in the literature. Our aim was to analyse concordance between BRAF IHC and BRAF molecular analysis in a large, mono-institutional CRC whole-slide, case series with laboratory validation.
View Article and Find Full Text PDFDNA Mismatch Repair System Imbalances in Breast Adenocarcinoma.
Cancer Diagn Progn
March 2023
Breast Unit, 1st Department of Obstetrics and Gynaecology, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece.
DNA mismatch repair system (MMR) is considered a leading genetic mechanism in stabilizing DNA structure and maintaining its function. DNA MMR is a highly conserved system in bacteria, prokaryotic, and eukaryotic cells, and provides the highest protection to DNA by repairing micro-structural alterations. DNA MMR proteins are involved in the detection and repair of intra-nucleotide base-to-base errors inside the complementary DNA strand recognizing the recently synthesized strand from the parental template.
View Article and Find Full Text PDFImmune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variant.
Virchows Arch
June 2023
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Article Synopsis
- Immune checkpoint inhibitors, specifically PD-1 inhibitors, show potential as a new treatment for patients with Richter transformation-diffuse large B-cell lymphoma variant (RT-DLBCL), based on a study of 64 patients.
- The study categorized tumor expression levels of PD-1, PD-L1, CD30, and microsatellite instability, identifying a subset of patients (43.7%) with an "immune evasion phenotype" (IEP+) that displayed significantly higher levels of PD1-positive tumor-infiltrating lymphocytes (TILs).
- Patients with brisk PD1+ TILs had a notably better overall survival rate compared to those with lower levels of TILs, indicating a correlation between immune response
The Effect of Tobacco Smoke -Nitrosamines, NNK and NDEA, and Nicotine, on DNA Mismatch Repair Mechanism and miRNA Markers, in Hypopharyngeal Squamous Cell Carcinoma: An In Vivo Model and Clinical Evidence.
Curr Oncol
August 2022
The Yale Larynx Laboratory, Department of Surgery, Yale School of Medicine, New Haven, CT 06510, USA.
Deregulation of the DNA mismatch repair (MMR) mechanism has been linked to poor prognosis of upper aerodigestive tract cancers. Our recent in vitro data have provided evidence of crosstalk between deregulated miRNAs and MMR genes, caused by tobacco smoke (TS) -Nitrosamines, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in hypopharyngeal cells. Here, we explored whether chronic exposure to TS components can affect MMR mechanism and miRNA profiles in hypopharyngeal mucosa.
View Article and Find Full Text PDFMismatch repair system in colorectal cancer. Frequency, cancer phenotype, and follow-up.
Rev Gastroenterol Mex (Engl Ed)
November 2022
Departamento de Patología, Instituto Nacional de Ciencias Médicas y Nutrición «Salvador Zubirán», Mexico City, Mexico. Electronic address:
Introduction And Aims: A frequent task in the study of colorectal carcinomas (CRC) is to identify tumors harboring deficient DNA mismatch repair systems (dMMR), which are associated with microsatellite instability. Given that there is scant information on those tumors in Mexican patients, our aim was to describe their frequency, clinical and pathologic characteristics, and results, which are necessary for future trials.
Materials And Methods: A consecutive series of CRC patients, treated and followed at a tertiary care center was performed.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!